Health Canada
- Status: approved
Renin-angiotensin-aldosterone system inhibitors (Renin-angiotensin-aldosterone system inhibitors) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
National Heart Centre Singapore is the originator. The local marketing authorisation holder may differ — check the official source linked above.